MPM
ABBV icon

Meritage Portfolio Management’s AbbVie ABBV Stock Holding History

Meritage Portfolio Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.64M Sell
37,798
-1,074
-3% -$245K 0.57% 43
2025
Q3 		$9M Buy
38,872
+7,057
+22% +$1.44M 0.6% 42
2025
Q2 		$5.91M Sell
31,815
-149
-0.5% -$27.7K 0.37% 71
2025
Q1 		$6.7M Sell
31,964
-1,035
-3% -$201K 0.44% 63
2024
Q4 		$5.86M Sell
32,999
-536
-2% -$98.5K 0.36% 69
2024
Q3 		$6.62M Sell
33,535
-598
-2% -$112K 0.41% 68
2024
Q2 		$5.85M Buy
34,133
+1,119
+3% +$185K 0.37% 80
2024
Q1 		$6.01M Buy
33,014
+28,456
+624% +$4.9M 0.38% 79
2023
Q4 		$706K Buy
4,558
+888
+24% +$129K 0.05% 219
2023
Q3 		$547K Sell
3,670
-76
-2% -$11.2K 0.04% 231
2023
Q2 		$505K Sell
3,746
-133
-3% -$19.5K 0.04% 243
2023
Q1 		$618K Sell
3,879
-19,157
-83% -$2.93M 0.05% 197
2022
Q4 		$3.72M Buy
23,036
+1,191
+5% +$183K 0.29% 120
2022
Q3 		$2.93M Buy
21,845
+1,038
+5% +$149K 0.24% 123
2022
Q2 		$3.19M Sell
20,807
-10,906
-34% -$1.67M 0.25% 126
2022
Q1 		$5.14M Buy
31,713
+433
+1% +$62.9K 0.32% 97
2021
Q4 		$4.24M Sell
31,280
-2,629
-8% -$311K 0.24% 113
2021
Q3 		$3.66M Sell
33,909
-422
-1% -$48.2K 0.22% 122
2021
Q2 		$3.87M Buy
34,331
+114
+0.3% +$12.8K 0.23% 129
2021
Q1 		$3.7M Sell
34,217
-2,130
-6% -$228K 0.25% 123
2020
Q4 		$3.9M Buy
36,347
+9,801
+37% +$942K 0.29% 80
2020
Q3 		$2.33M Buy
+26,546
New +$2.5M 0.21% 130

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Meritage Portfolio Management's ABBV Position: Q4 2025 in Review

Meritage Portfolio Management reduced its AbbVie (ABBV) stake by 2.8% in Q4 2025, selling an estimated $245K and leaving 37,798 shares worth $8.64M. The position accounts for 0.57% of the portfolio, ranked #43.

Meritage Portfolio Management first reported a position in ABBV in Q3 2020 and has held it in 22 quarters since. The position peaked at $9M in Q3 2025. 4,160 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Meritage Portfolio Management held 37,798 shares of AbbVie worth $8.64M as of Q4 2025.
  • Meritage Portfolio Management sold 1,074 AbbVie shares in Q4 2025, an estimated $245K.
  • AbbVie made up 0.57% of Meritage Portfolio Management's portfolio in Q4 2025, its #43 holding.
  • Meritage Portfolio Management first reported a position in AbbVie in Q3 2020 and has held it in 22 quarters since.
  • Meritage Portfolio Management's AbbVie position peaked at $9M in Q3 2025.
  • 4,160 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.